US$ 20.91
fda bpc 157 not approved for human use statement The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Peptide BPC-157 - Does It
Description
Its especially helpful for surgeries involving mucosal, vascular, or tendon healing (think bowel or ligament repairs)

Certain drug classes are restricted only in sports where they confer identified advantages like calming heart rate

(2003) NAB2, a corepressor of EGR-1, inhibits vascular endothelial growth factor-mediated gene induction and angiogenic responses of endothelial cells

For Paradigm Peptides, the issue was more severe: selling controlled substances (testosterone) under false SARM labels is a federal crime with no grey area
